Delcath Systems
DCTH
121 hedge funds and large institutions have $152M invested in Delcath Systems in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 23 closing their positions.
17% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 23
2% more funds holding
Funds holding: 119 → 121 (+2)
7% more call options, than puts
Call options by funds: $2.71M | Put options by funds: $2.53M
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.53% less ownership
Funds ownership: 48.5% → 46.97% (-1.5%)
12% less capital invested
Capital invested by funds: $173M → $152M (-$21.1M)
Top Buyers
Top Sellers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
-$4.46M |
| 2 |
Goldman Sachs
New York
|
-$2.89M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.82M |
| 4 |
PIP
Palisades Investment Partners
Santa Monica,
California
|
-$2.45M |
| 5 |
Renaissance Technologies
New York
|
-$2M |
DCTH Hedge Fund Activity: Q1 2026 in Review
121 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Delcath Systems (DCTH) for Q1 2026, worth a combined $152M — down 12% from $173M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new DCTH positions and 23 closed out — a net gain of 4 holders — while 37 added to existing stakes and 36 trimmed.
The largest buyer was Propel Bio Management, adding an estimated $5.24M. The largest seller was ExodusPoint Capital Management, cutting an estimated $4.46M.
- 121 institutional investors held Delcath Systems (DCTH) as of Q1 2026, up from 119 in Q4 2025.
- Funds reported $152M of Delcath Systems stock for Q1 2026, down 12% quarter-over-quarter.
- 27 funds opened new Delcath Systems positions in Q1 2026 and 23 closed out, a net change of +4 holders.
- The largest Delcath Systems buyer in Q1 2026 was Propel Bio Management, an estimated $5.24M added.
- The largest Delcath Systems seller in Q1 2026 was ExodusPoint Capital Management, an estimated $4.46M sold.
Based on aggregated 13F filings for Q1 2026.